z-logo
open-access-imgOpen Access
WHY DO PRESCRIPTION DRUG PRICES INCREASE? STATE MEDICAID EXPANSION, EXECUTIVE COMPENSATION AND CORPORATE GOVERNANCE
Author(s) -
Mosab Hammoudeh,
Amrita Nain Nain,
Tarek Zaher Zaher
Publication year - 2022
Publication title -
international journal of finance
Language(s) - English
Resource type - Journals
ISSN - 2520-0852
DOI - 10.47941/ijf.984
Subject(s) - corporate governance , executive compensation , business , prescription drug , stock (firearms) , shock (circulatory) , accounting , medical prescription , economics , finance , medicine , mechanical engineering , engineering , pharmacology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom